JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us
Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

Vía del complemento: patrón molecular de riesgo de enfermedades cardiovasculares en pacientes con nefropatía diabética

  • 0Affiliated Hospital of Hebei University of Engineering, Department of Nephrology, The Key Laboratory of Basic Research on Blood Purification Application in Hebei Province, Handan City, Hebei Province, China.
Journal of Medical Biochemistry +

|

21 de agosto de 2025

|

21 de agosto de 2025

Ver abstracta en PubMed

Resumen

Este resumen es generado por máquina.

Los niveles elevados de ácido úrico (UA) y C1q son factores de riesgo independientes para la enfermedad cardiovascular (ECV) en pacientes con nefropatía diabética (DN). Los niveles más altos de UA y C1q se correlacionan con un mayor riesgo de ECV, lo que ayuda en la evaluación del paciente.

Área De La Ciencia

  • Nefrología
  • Cardiología
  • Diabetología

Sus Antecedentes

  • La nefropatía diabética (DN) es una complicación común de la diabetes mellitus, que aumenta el riesgo de enfermedad cardiovascular (ECV) a medida que progresa la disfunción renal.
  • La gestión eficaz de la DN y la CVD requiere identificar y abordar los factores de riesgo compartidos.

Objetivo Del Estudio

  • Identificar factores de riesgo independientes para la enfermedad cardiovascular (ECV) en pacientes con nefropatía diabética (DN).
  • Investigar la relación entre el ácido úrico (UA), la C1q, la proteína C reactiva (CRP) y el riesgo de ECV en pacientes con ADN.
  • Evaluar la eficacia predictiva de UA y C1q para la ECV en DN.

Principales Métodos

  • Un estudio transversal en el que participaron 98 pacientes con DN, divididos en grupos de DN (n=58) y DN/CVD (n=40).
  • Se utilizaron análisis de regresión logística univariados y multivariados para identificar factores de riesgo independientes de ECV.
  • El modelado de regresión y el análisis de la curva ROC evaluaron la relación entre UA, C1q, CRP y riesgo de ECV.

Principales Resultados

  • Los niveles elevados de ácido úrico (UA) y C1q se identificaron como factores de riesgo independientes de ECV en pacientes con DN.
  • Se observó una asociación lineal entre los niveles de UA/C1q y el riesgo de ECV.
  • C1q demostró un rendimiento predictivo superior para la ECV en comparación con UA y CRP.

Conclusiones

  • El aumento de los niveles de UA y C1q eleva significativamente el riesgo de ECV en pacientes con DN.
  • La UA y la C1q son indicadores valiosos para evaluar el desarrollo y la progresión de la ECV en el ADN.
  • Estos marcadores ofrecen un valor de evaluación de apoyo para la condición clínica de los pacientes con DN.

Palabras clave:

Videos de Conceptos Relacionados

Pathophysiology of Diabetes 01:20

1.2K

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Chronic Kidney Disease II: Clinical Manifestations 01:24

87

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

Complement System 01:27

2.7K

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...

Coronary Artery Disease I: Introduction 01:30

55

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Heart Failure II: Pathophysiology 01:29

38

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation 01:21

34

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...